Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma
Abstract
Citations
-
1 0 0
CrossRef
-
0
Web of Science
-
1 0 7
Scopus
Authors (14)
Cite as
Full text
full text is not available in portal
Details
- Category:
- Magazine publication
- Type:
- Magazine publication
- Published in:
-
ANNALS OF ONCOLOGY
no. 29,
edition 5,
pages 1266 - 1272,
ISSN: 0923-7534 - ISSN:
- 0923-7534
- Publication year:
- 2018
- DOI:
- Digital Object Identifier (open in new tab) 10.1093/annonc/mdy056
- Verified by:
- No verification
seen 97 times